These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26386393)

  • 1. Neuroprotective effects of chrysin: From chemistry to medicine.
    Nabavi SF; Braidy N; Habtemariam S; Orhan IE; Daglia M; Manayi A; Gortzi O; Nabavi SM
    Neurochem Int; 2015 Nov; 90():224-31. PubMed ID: 26386393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
    Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
    Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine.
    Nabavi SF; Braidy N; Habtemariam S; Sureda A; Manayi A; Nabavi SM
    Curr Top Med Chem; 2016; 16(17):1910-5. PubMed ID: 26845554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches.
    Talebi M; Talebi M; Farkhondeh T; Kopustinskiene DM; Simal-Gandara J; Bernatoniene J; Samarghandian S
    Biomed Pharmacother; 2021 Sep; 141():111906. PubMed ID: 34328092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders.
    Goyal A; Singh G; Verma A
    CNS Neurol Disord Drug Targets; 2023; 22(6):789-800. PubMed ID: 35657041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action.
    Mani R; Natesan V
    Phytochemistry; 2018 Jan; 145():187-196. PubMed ID: 29161583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats.
    He XL; Wang YH; Bi MG; Du GH
    Eur J Pharmacol; 2012 Apr; 680(1-3):41-8. PubMed ID: 22314218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorogenic Acid and Mental Diseases: From Chemistry to Medicine.
    Nabavi SF; Tejada S; Setzer WN; Gortzi O; Sureda A; Braidy N; Daglia M; Manayi A; Nabavi SM
    Curr Neuropharmacol; 2017; 15(4):471-479. PubMed ID: 27012954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB.
    Bae Y; Lee S; Kim SH
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):56-64. PubMed ID: 21515303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.
    Ashaari Z; Hadjzadeh MA; Hassanzadeh G; Alizamir T; Yousefi B; Keshavarzi Z; Mokhtari T
    J Mol Neurosci; 2018 Aug; 65(4):491-506. PubMed ID: 30083786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic chrysin silica nanomaterials behavior in an amyloidogenic environment.
    Nday CM; Eleftheriadou D; Jackson G
    Hell J Nucl Med; 2019; 22 Suppl():42-50. PubMed ID: 30877722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders.
    Mishra A; Mishra PS; Bandopadhyay R; Khurana N; Angelopoulou E; Paudel YN; Piperi C
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.
    Stompor-Gorący M; Bajek-Bil A; Machaczka M
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34198618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-κB and JNK activations in microglia cells.
    Ha SK; Moon E; Kim SY
    Neurosci Lett; 2010 Nov; 485(3):143-7. PubMed ID: 20813161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases.
    Giacoppo S; Galuppo M; Montaut S; Iori R; Rollin P; Bramanti P; Mazzon E
    Fitoterapia; 2015 Oct; 106():12-21. PubMed ID: 26254971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Chrysin Against Drugs and Toxic Agents.
    Samarghandian S; Farkhondeh T; Azimi-Nezhad M
    Dose Response; 2017; 15(2):1559325817711782. PubMed ID: 28694744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective actions of flavonoids.
    Gutierrez-Merino C; Lopez-Sanchez C; Lagoa R; Samhan-Arias AK; Bueno C; Garcia-Martinez V
    Curr Med Chem; 2011; 18(8):1195-212. PubMed ID: 21291366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chrysin: Pharmacological and therapeutic properties.
    Naz S; Imran M; Rauf A; Orhan IE; Shariati MA; Iahtisham-Ul-Haq ; IqraYasmin ; Shahbaz M; Qaisrani TB; Shah ZA; Plygun S; Heydari M
    Life Sci; 2019 Oct; 235():116797. PubMed ID: 31472146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative diseases: From available treatments to prospective herbal therapy.
    Solanki I; Parihar P; Parihar MS
    Neurochem Int; 2016 May; 95():100-8. PubMed ID: 26550708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.